Background
Despite being in clinical remission, many people with Inflammatory Bowel Disease (IBD) live with fatigue, chronic abdominal pain and bowel urgency or incontinence that limit their quality of life. We aim to test the effectiveness of an online self-management programme (BOOST), developed using cognitive behavioural principles and a theoretically informed logic model, and delivered with facilitator support.
Primary research question
In people with IBD who report symptoms of fatigue, pain or urgency and express a desire for intervention, does a facilitator-supported tailored (to patient needs) online self-management programme for fatigue, pain and faecal urgency/incontinence improve IBD-related quality of life (measured using the UK-IBDQ) and global rating of symptom relief (0-10 scale) compared with care as usual?
Methods
A pragmatic two-arm, parallel group Randomised Controlled Trial (RCT), of a 12-session facilitator-supported online cognitive-behavioural self-management programme versus care as usual to manage symptoms of fatigue, pain, and faecal urgency/incontinence in IBD. Patients will be recruited through a previous large-scale survey of unselected people with inflammatory bowel disease. The UK Inflammatory Bowel Disease Questionnaire and global rating of symptom relief at 6 months are the co-primary outcomes, with multiple secondary outcomes measured also at 6 and 12 months post randomisation to assess maintenance. The RCT has an embedded pilot study, health economics evaluation and process evaluation.
We will randomise 680 patients, 340 in each group. Demographic characteristics and outcome measures will be presented for both study groups at baseline. The UK-IBDQ and global rating of symptom relief at 6 and 12 months post randomisation will be compared between the study groups.
Discussion
The BOOST online self-management programme for people with IBD-related symptoms of fatigue, pain and urgency has been designed to be easily scalable and implemented. If it is shown to improve patients’ quality of life, this trial will enable clinicians and patients to make informed management decisions. This is the first trial, to our knowledge, focused on multiple symptoms prioritised by both people with IBD and health professionals.
Trial registration
registered at ISRCTN, ID: ISRCTN71618461. Registered 09/09/2019. Available at: http://www.isrctn.com/ISRCTN71618461
Protocol version 3: 28.04.2020

Figure 1
This is a list of supplementary files associated with this preprint. Click to download.
Loading...
Posted 07 Jun, 2021
On 15 Jul, 2021
Received 10 Jul, 2021
Received 08 Jul, 2021
On 07 Jul, 2021
Invitations sent on 06 Jul, 2021
On 23 May, 2021
On 23 May, 2021
On 13 Nov, 2020
Posted 07 Jun, 2021
On 15 Jul, 2021
Received 10 Jul, 2021
Received 08 Jul, 2021
On 07 Jul, 2021
Invitations sent on 06 Jul, 2021
On 23 May, 2021
On 23 May, 2021
On 13 Nov, 2020
Background
Despite being in clinical remission, many people with Inflammatory Bowel Disease (IBD) live with fatigue, chronic abdominal pain and bowel urgency or incontinence that limit their quality of life. We aim to test the effectiveness of an online self-management programme (BOOST), developed using cognitive behavioural principles and a theoretically informed logic model, and delivered with facilitator support.
Primary research question
In people with IBD who report symptoms of fatigue, pain or urgency and express a desire for intervention, does a facilitator-supported tailored (to patient needs) online self-management programme for fatigue, pain and faecal urgency/incontinence improve IBD-related quality of life (measured using the UK-IBDQ) and global rating of symptom relief (0-10 scale) compared with care as usual?
Methods
A pragmatic two-arm, parallel group Randomised Controlled Trial (RCT), of a 12-session facilitator-supported online cognitive-behavioural self-management programme versus care as usual to manage symptoms of fatigue, pain, and faecal urgency/incontinence in IBD. Patients will be recruited through a previous large-scale survey of unselected people with inflammatory bowel disease. The UK Inflammatory Bowel Disease Questionnaire and global rating of symptom relief at 6 months are the co-primary outcomes, with multiple secondary outcomes measured also at 6 and 12 months post randomisation to assess maintenance. The RCT has an embedded pilot study, health economics evaluation and process evaluation.
We will randomise 680 patients, 340 in each group. Demographic characteristics and outcome measures will be presented for both study groups at baseline. The UK-IBDQ and global rating of symptom relief at 6 and 12 months post randomisation will be compared between the study groups.
Discussion
The BOOST online self-management programme for people with IBD-related symptoms of fatigue, pain and urgency has been designed to be easily scalable and implemented. If it is shown to improve patients’ quality of life, this trial will enable clinicians and patients to make informed management decisions. This is the first trial, to our knowledge, focused on multiple symptoms prioritised by both people with IBD and health professionals.
Trial registration
registered at ISRCTN, ID: ISRCTN71618461. Registered 09/09/2019. Available at: http://www.isrctn.com/ISRCTN71618461
Protocol version 3: 28.04.2020

Figure 1
This is a list of supplementary files associated with this preprint. Click to download.
Loading...